Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3P6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,977
Award facts
- Contract value 100% obligated
- $15,977.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,977.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 27, 2026, with completion targeted for January 28, 2026. The award was made on a competitive, non-set-aside basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent (dupilumab) is a specialty biologic medication used primarily for treating atopic dermatitis, asthma, and other inflammatory conditions, representing the type of specialized pharmaceutical product that the DLA procures to support military treatment facilities and veteran healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements across multiple therapeutic domains through its extensive network and distribution capabilities. The non-set-aside competitive award reflects the company's demonstrated capability to meet stringent federal procurement standards for critical pharmaceutical supplies.
Quick answers
Who was awarded contract SPE2DR26F3P6X?
SPE2DR26F3P6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F3P6X worth?
The government has obligated $15,977 on SPE2DR26F3P6X.
Is contract SPE2DR26F3P6X an order under another contract?
Yes. SPE2DR26F3P6X is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P6X competed?
The extent of competition for SPE2DR26F3P6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award